Exagen, Inc. (XGN)
3.84
+0.01
(+0.26%)
USD |
NASDAQ |
May 21, 09:52
Exagen Free Cash Flow : -14.13M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Veracyte, Inc. | 155.34M |
| Insight Molecular Diagnostics, Inc. | -27.46M |
| bioAffinity Technologies, Inc. | -10.93M |
| GRAIL, Inc. | -292.33M |
| FONAR Corp. | 4.167M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.42M |
| Cash from Investing (Quarterly) | -0.228M |
| Cash from Financing (Quarterly) | -0.062M |
| Free Cash Flow Per Share (Quarterly) | -0.4462 |
| Free Cash Flow to Equity (Quarterly) | -10.12M |
| Free Cash Flow to Firm (Quarterly) | -9.366M |
| Free Cash Flow Yield | -16.09% |